Rx only · Tablet, Film Coated · Oral
Pazopanib Hydrochloride
Brands: Votrient · Pazopanib · Pazopanib Hydrochloride
3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US3 NDCs
3 active makers
3 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
247
Rx · 2026 Q1
23K
Units dispensed
-25%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it3 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Torrent Pharmaceuticals Limited | unknown | 3 | SUPPLYING |
| Novugen Pharma (USA) LLC. | unknown | 1 | SUPPLYING |
| Novartis Pharmaceuticals Corporation | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Nov 20, 2023RECALLRecall (Class III): Votrient (pazopanib) 200 mg tablets, 120-count bottle, Rx Only, Manufactured by: Siegried Barbera, S.L., Barbera del Va…
Failed Dissolution Specifications — Recalling firm: Siegfried Barbera, SL — Nationwide
Pill